Home > Income Statement > IPCA LABORATORIES

IPCA LABORATORIES
Revenue

    Back to Income Statement
IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for IPCA LABORATORIES
Please provide your vote to see the results

IPCA LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹8,897 Cr₹7,662 Cr₹6,204 Cr₹5,797 Cr₹5,395 Cr

What is the latest Revenue of IPCA LABORATORIES ?

The latest Revenue ratio of IPCA LABORATORIES is ₹8,897 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹8,897 Cr
Mar2025₹7,662 Cr
Mar2024₹6,204 Cr
Mar2023₹5,797 Cr
Mar2022₹5,395 Cr

How is Revenue of IPCA LABORATORIES Trending?

Years Revenue % Change
Mar2026 ₹8,897 Cr
16.11
Mar2025 ₹7,662 Cr
23.50
Mar2024 ₹6,204 Cr
7.03
Mar2023 ₹5,797 Cr
7.45
Mar2022 ₹5,395 Cr -

Compare Revenue of peers of IPCA LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
IPCA LABORATORIES ₹49,466.4 Cr 1.2% 0.2% 53.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹437,963.0 Cr 2.7% 1.4% 4.3% Stock Analytics
DIVIS LABORATORIES ₹269,451.0 Cr 4.5% 6.3% 50.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,456.0 Cr 1.8% -1.3% 31.4% Stock Analytics
DR REDDYS LABORATORIES ₹113,664.0 Cr 0.8% 12.5% 14.1% Stock Analytics
CIPLA ₹113,246.0 Cr 1.6% 4.4% -9.1% Stock Analytics


IPCA LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
IPCA LABORATORIES

1.2%

0.2%

53.1%

SENSEX

7%

9.6%

-6.7%


You may also like the below Video Courses